Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam flag Vietnam · Delayed Price · Currency is VND
49,900
+1,000 (2.04%)
At close: Nov 3, 2026

Ha Tay Pharmaceutical JSC Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Net Income
33,97453,65771,77285,05695,21167,946
Depreciation & Amortization
37,70224,14320,48117,07817,44816,651
Loss (Gain) From Sale of Assets
-9,483-20,385-14,478-4,608-9,923-
Other Operating Activities
-4,1911,9135,087-1,3522,653-14,450
Change in Accounts Receivable
-12,66462,42628,972147,484-159,47751,385
Change in Inventory
272,47116,499-149,02781,720-120,92233,804
Change in Accounts Payable
-154,94088,46867,274-55,823133,037-182,898
Change in Other Net Operating Assets
-9,177-1,001-2,1211,2452,5024,269
Operating Cash Flow
153,691225,71927,959270,799-39,471-23,293
Operating Cash Flow Growth
177.79%707.32%-89.68%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Capital Expenditures
-24,977-48,759-143,132-366,523-246,553-60,524
Sale of Property, Plant & Equipment
7,055126.3415028186.82244.42
Investment in Securities
-8,000---297,000-350,000
Other Investing Activities
15,86914,1037,2153,62726,265106.17
Investing Cash Flow
51,915-94,529-125,767-409,61576,799-410,174

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Long-Term Debt Issued
-648,788746,915782,402774,504741,472
Total Debt Issued
428,474648,788746,915782,402774,504741,472
Long-Term Debt Repaid
--785,911-780,429-615,546-727,089-656,225
Total Debt Repaid
-563,973-785,911-780,429-615,546-727,089-656,225
Net Debt Issued (Repaid)
-135,499-137,123-33,513166,85747,41485,247
Issuance of Common Stock
---180,600-367,749
Common Dividends Paid
---80,194--51,288-20,359
Financing Cash Flow
-135,499-137,123-113,707347,457-3,873432,637

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.06-0.06-5.4617.778.574.8
Net Cash Flow
70,107-5,933-211,521208,65833,463-825.13

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Free Cash Flow
128,714176,961-115,173-95,725-286,024-83,817
Free Cash Flow Growth
160.20%-----
Free Cash Flow Margin
5.40%7.37%-5.52%-4.79%-15.57%-5.21%
Free Cash Flow Per Share
-1934.16-1155.99-1564.44-3196.95-944.08
Levered Free Cash Flow
118,663164,407-68,973-134,881-308,353-114,140
Unlevered Free Cash Flow
126,203172,567-60,567-122,319-299,413-105,394

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Cash Interest Paid
1,76713,10713,41720,10014,35013,953
Cash Income Tax Paid
2,55215,97518,89426,10621,04916,423
Change in Working Capital
95,690166,392-54,902174,625-144,860-93,440